معرفی
Dr. Sumit Sahni is an Adjunct Associate Professor at Sydney Medical School, Northern Clinical School, within the Faculty of Medicine and Health at the University of Sydney. His research primarily focuses on cancer biology, particularly pancreatic cancer and autophagy, with significant contributions to understanding tumor progression and developing novel therapeutic strategies.
Research Interests:
- Cancer biology with emphasis on pancreatic cancer
- Autophagy as a therapeutic target in cancer
- Triple negative breast cancer research
- Cancer biomarker discovery and validation
- Tumor microenvironment and metastasis
His work extensively explores the molecular mechanisms underlying cancer progression, particularly the role of autophagy in pancreatic cancer. Dr. Sahni's research has identified potential biomarkers for early detection and personalized treatment approaches. His publications demonstrate a consistent focus on translational research, bridging basic science discoveries with clinical applications.
Grants and Funding:
- Overcoming Chemotherapy Resistance in Triple Negative Breast Cancers (2023)
- Development of Biomarker Tests for Early Detection/Diagnosis of Pancreatic Cancer
- Development of Personalised Treatment Pathways for Pancreatic Cancer Patients
- Novel Biomarker Panel for Predicting Chemo-resistance in Pancreatic Cancer
- Development of Novel Therapy Targeting Autophagy Against Triple Negative Breast Cancers
Dr. Sahni actively supervises PhD and master's students and offers research opportunities in pancreatic cancer metastasis and autophagy targeting. His collaborative approach involves working with multidisciplinary teams to advance cancer research and improve patient outcomes.
